Difference between revisions of "Part:BBa K4165088"
Ahmedsameh (Talk | contribs) |
Omnia Alaa11 (Talk | contribs) |
||
(6 intermediate revisions by 4 users not shown) | |||
Line 8: | Line 8: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | This type of family encodes for a type of inhibitor that contains a motif which consists of 8 cysteine residues capable of forming four disulfide bonds at the core of the protease, thus inhibiting its action. The main function of this inhibitor is to prevent elastase-mediated tissue proteolysis. This type of inhibitor is very effective and has high affinity for trypsin-like proteases (serine proteases), and in our case it would act as an inhibitor for the trypsin-like catalytic domain of serine protease HtrA1[1 | + | This type of family encodes for a type of inhibitor that contains a motif which consists of 8 cysteine residues capable of forming four disulfide bonds at the core of the protease, thus inhibiting its action. The main function of this inhibitor is to prevent elastase-mediated tissue proteolysis. This type of inhibitor is very effective and has high affinity for trypsin-like proteases (serine proteases), and in our case it would act as an inhibitor for the trypsin-like catalytic domain of serine protease HtrA1<sup>[1-3]</sup>. |
<!-- --> | <!-- --> | ||
− | <span class='h3bb'>Sequence and Features</span> | + | ===<span class='h3bb'>Sequence and Features</span>=== |
<partinfo>BBa_K4165088 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4165088 SequenceAndFeatures</partinfo> | ||
Line 19: | Line 19: | ||
===Functional Parameters=== | ===Functional Parameters=== | ||
− | |||
− | |||
− | Isoelectric point (PI) | + | <html> |
− | 8.641 | + | <style> |
+ | table, th, td { | ||
+ | border:1px solid black; margin-left:auto;margin-right:auto; | ||
+ | } | ||
+ | </style> | ||
+ | <body> | ||
+ | <table style="width:65%"> | ||
+ | <table> | ||
+ | <tr> | ||
+ | <th>GC Content%</th> | ||
+ | <th>Isoelectric point (PI)</th> | ||
+ | <th>Charge at pH 7</th> | ||
+ | <th>Molecular Weight (Protein)</th> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <td>67.5%</td> | ||
+ | <td>8.641</td> | ||
+ | <td>6.373</td> | ||
+ | <td>12.27</td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | </body> | ||
+ | </html> | ||
− | |||
− | |||
− | + | ===Modeling=== | |
− | + | ||
− | + | ||
− | === | + | |
X-ray, NMR, and the predicted structures (AlphaFold2) are all present. | X-ray, NMR, and the predicted structures (AlphaFold2) are all present. | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | + | <html> | |
− | https:// | + | <p><img src="https://static.igem.wiki/teams/4165/wiki/model3.jpg" style="margin-left:200px;" alt="" width="500" /></p> |
− | + | </html> | |
− | + | ||
− | + | Figure 1.: A graphical illustration showing the domains of TRIM21 (X-Ray diffraction). | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
+ | |||
+ | <html> | ||
+ | <p><img src="https://static.igem.wiki/teams/4165/wiki/model4.jpg" style="margin-left:200px;" alt="" width="500" /></p> | ||
+ | </html> | ||
+ | |||
+ | Figure 2.: A graphical illustration showing the domains of TRIM21 (NMR). | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | <html> | ||
+ | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/switches/9-alphafold.png" style="margin-left:200px;" alt="" width="500" /></p> | ||
+ | </html> | ||
+ | |||
+ | Figure 3.: A graphical illustration showing the domains of TRIM21 (AlphaFold). | ||
===References=== | ===References=== | ||
− | 1. Clauss, A., Lilja, H., & Lundwall, Å. (2005). The evolution of a genetic locus encoding small serine proteinase inhibitors. Biochemical and biophysical research communications, 333(2), 383-389. | + | 1. Clauss, A., Lilja, H., & Lundwall, Å. (2005). The evolution of a genetic locus encoding small serine proteinase inhibitors. Biochemical and biophysical research communications, 333(2), 383-389.<br> |
− | 2. Eigenbrot, C., Ultsch, M., Lipari, M. T., Moran, P., Lin, S. J., Ganesan, R., ... & Kirchhofer, D. (2012). Structural and functional analysis of HtrA1 and its subdomains. Structure, 20(6), 1040-1050. | + | 2. Eigenbrot, C., Ultsch, M., Lipari, M. T., Moran, P., Lin, S. J., Ganesan, R., ... & Kirchhofer, D. (2012). Structural and functional analysis of HtrA1 and its subdomains. Structure, 20(6), 1040-1050.<br> |
− | 3. Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., ... & Ehrmann, M. (2005). Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proceedings of the National Academy of Sciences, 102(17), 6021-6026. | + | 3. Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., ... & Ehrmann, M. (2005). Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proceedings of the National Academy of Sciences, 102(17), 6021-6026.<br> |
<partinfo>BBa_K4165088 parameters</partinfo> | <partinfo>BBa_K4165088 parameters</partinfo> | ||
<!-- --> | <!-- --> |
Latest revision as of 12:11, 13 October 2022
WAP-four disulfide core domain 14 serine protease inhibitor.
This basic part encodes Human serine protease inhibitor WAP-four disulfide core domain 14 which is able to inhibit HtrA1 (BBa_K4165004).
Usage and Biology
This type of family encodes for a type of inhibitor that contains a motif which consists of 8 cysteine residues capable of forming four disulfide bonds at the core of the protease, thus inhibiting its action. The main function of this inhibitor is to prevent elastase-mediated tissue proteolysis. This type of inhibitor is very effective and has high affinity for trypsin-like proteases (serine proteases), and in our case it would act as an inhibitor for the trypsin-like catalytic domain of serine protease HtrA1[1-3].
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 132
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 189
- 1000COMPATIBLE WITH RFC[1000]
Functional Parameters
GC Content% | Isoelectric point (PI) | Charge at pH 7 | Molecular Weight (Protein) |
---|---|---|---|
67.5% | 8.641 | 6.373 | 12.27 |
Modeling
X-ray, NMR, and the predicted structures (AlphaFold2) are all present.
Figure 1.: A graphical illustration showing the domains of TRIM21 (X-Ray diffraction).
Figure 2.: A graphical illustration showing the domains of TRIM21 (NMR).
Figure 3.: A graphical illustration showing the domains of TRIM21 (AlphaFold).
References
1. Clauss, A., Lilja, H., & Lundwall, Å. (2005). The evolution of a genetic locus encoding small serine proteinase inhibitors. Biochemical and biophysical research communications, 333(2), 383-389.
2. Eigenbrot, C., Ultsch, M., Lipari, M. T., Moran, P., Lin, S. J., Ganesan, R., ... & Kirchhofer, D. (2012). Structural and functional analysis of HtrA1 and its subdomains. Structure, 20(6), 1040-1050.
3. Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., ... & Ehrmann, M. (2005). Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proceedings of the National Academy of Sciences, 102(17), 6021-6026.